PEGASYS (peginterferon alfa-2a 40KD)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PEGASYS (peginterferon alfa-2a 40KD), covering 2016-06-08 to 2016-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [Phase 4]